Spatial Immune Remodeling Across the Gallbladder Carcinogenesis Spectrum: A Multicenter Digital Pathology Study
Tamta Kveliashvili1, George Didava1, George Burkadze1
1Department of Pathology, Tbilisi State Medical University, Tbilisi, Georgia.
World Journal of Oncology
|July 23, 2026
Summary
Gallbladder cancer progression involves immune changes, with more suppressive cells and fewer cytotoxic T cells at tumor sites. This study quantifies these immune microenvironment shifts in gallbladder lesions.
Area of Science:
- Oncology
- Immunology
- Digital Pathology
Background:
- Gallbladder carcinoma (GBC) is aggressive, often diagnosed late with metastasis.
- The tumor immune landscape during GBC development is poorly understood.
- Understanding immune changes is crucial for GBC diagnosis and treatment.
Purpose of the Study:
- To quantitatively assess immune microenvironment alterations in gallbladder lesions.
- To analyze immune cell distribution across the spectrum of gallbladder carcinogenesis.
- To identify potential immune biomarkers for GBC aggressiveness.
Main Methods:
- Retrospective multicenter study of 90 gallbladder specimens.
- Immunohistochemistry for CD8, FOXP3, and CD163.
- Digital pathology analysis for immune cell quantification and spatial distribution.
- Calculation of composite immune indices, including an immune suppression index.
Main Results:
- Progressive immune landscape remodeling observed across gallbladder lesions.
- Increased infiltration of regulatory T cells (FOXP3) and macrophages (CD163) in dysplasia and tumors.
- Cytotoxic T lymphocytes (CD8) showed spatial exclusion from tumor centers.
- Metastatic tumors had lower CD8+ T cells and higher immunosuppressive cells, with elevated immune suppression indices.
Conclusions:
- Gallbladder carcinogenesis involves immune microenvironment remodeling with immunosuppressive cell enrichment.
- Spatial restriction of cytotoxic T lymphocytes is observed in GBC.
- Digital pathology offers a reproducible method for assessing tumor-immune interactions.
- Immune architecture analysis may yield biomarkers for GBC aggressiveness.

